Aquestive Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 9.81 M | $40.81 M | 0.00% | 8.00% |
| BLACKROCK, INC. | 08/07/2026 | 8.07 M | $33.57 M | 7.46% | 6.58% |
| RTW INVESTMENTS, LP | 08/14/2026 | 7.43 M | $30.89 M | 0.00% | 6.06% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.58 M | $19.07 M | 3.17% | 3.74% |
| FEDERATED HERMES, INC. | 08/12/2026 | 3.11 M | $12.95 M | 5.86% | 2.54% |
| STATE STREET CORP | 08/07/2026 | 2.93 M | $12.18 M | 15.00% | 2.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.62 M | $10.91 M | 8.92% | 2.14% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2026 | 2.50 M | $10.40 M | 0.00% | 2.04% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.67 M | $6.94 M | -30.63% | 1.36% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.49 M | $6.18 M | -22.71% | 1.21% |
| PROPEL BIO MANAGEMENT, LLC | 08/13/2026 | 1.44 M | $6.00 M | 102.87% | 1.18% |
| WASATCH ADVISORS LP | 07/10/2026 | 1.39 M | $5.77 M | 57.78% | 1.13% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.28 M | $5.33 M | 12.45% | 1.05% |
| NUVEEN, LLC | 08/11/2026 | 1.22 M | $5.06 M | 379.44% | 0.99% |
| JANNEY MONTGOMERY SCOTT LLC | 08/05/2026 | 1.11 M | $4.60 M | 1.57% | 0.90% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 1.09 M | $4.53 M | 5.26% | 0.89% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/29/2026 | 1.05 M | $4.35 M | -3.37% | 0.85% |
| BARCLAYS PLC | 08/14/2026 | 996.67 K | $4.15 M | 24.71% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 949.80 K | $3.95 M | -0.70% | 0.77% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 942.93 K | $3.92 M | -30.05% | 0.77% |
| NORTHERN TRUST CORP | 08/13/2026 | 831.15 K | $3.46 M | 13.47% | 0.68% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 794.69 K | $3.31 M | -1.77% | 0.65% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 744.54 K | $3.10 M | -74.33% | 0.61% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 734.25 K | $3.05 M | 6.14% | 0.60% |
| MORGAN STANLEY | 08/13/2026 | 658.62 K | $2.74 M | -58.62% | 0.54% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 651.21 K | $2.71 M | 2.15% | 0.53% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 645.92 K | $2.69 M | 75.32% | 0.53% |
| EVERSTAR ASSET MANAGEMENT, LLC | 08/03/2026 | 611.94 K | $2.55 M | 10.62% | 0.50% |
| AWM INVESTMENT COMPANY, INC. | 08/14/2026 | 475.40 K | $1.98 M | 75.81% | 0.39% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 468.57 K | $1.95 M | 0.39% | 0.38% |
| BRACEBRIDGE CAPITAL, LLC | 08/14/2026 | 459.22 K | $1.91 M | 0.00% | 0.37% |
| UBS GROUP AG | 08/13/2026 | 458.41 K | $1.91 M | -1.25% | 0.37% |
| CITADEL ADVISORS LLC | 08/14/2026 | 452.20 K | $1.88 M | -19.99% | 0.37% |
| JANE STREET GROUP, LLC | 08/14/2026 | 437.49 K | $1.82 M | -57.53% | 0.36% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 416.25 K | $1.73 M | 100.00% | 0.34% |
| STIFEL FINANCIAL CORP | 08/12/2026 | 361.90 K | $1.51 M | 0.56% | 0.30% |
| MAN GROUP PLC | 08/14/2026 | 351.70 K | $1.46 M | 100.00% | 0.29% |
| HRT FINANCIAL LP | 08/14/2026 | 344.81 K | $1.43 M | 100.00% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 309.20 K | $1.29 M | -3.77% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 306.39 K | $1.27 M | 14.57% | 0.25% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 306.39 K | $1.27 M | 100.00% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 301.65 K | $1.25 M | 3.99% | 0.25% |
| MARSHALL WACE, LLP | 08/13/2026 | 285.66 K | $1.19 M | 1,459.70% | 0.23% |
| WALLEYE CAPITAL LLC | 08/03/2026 | 282.57 K | $1.18 M | -51.70% | 0.23% |
| SIMPLIFY ASSET MANAGEMENT INC. | 07/16/2026 | 278.72 K | $1.16 M | 18.97% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 275.54 K | $1.15 M | 7.98% | 0.22% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 260.48 K | $1.08 M | 15.17% | 0.21% |
| ROSALIND ADVISORS, INC. | 08/14/2026 | 250.00 K | $1.04 M | 0.00% | 0.20% |
| LATASH INVESTMENTS, LLC | 08/11/2026 | 243.13 K | $1.01 M | 0.00% | 0.20% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 234.00 K | $973.44 K | 0.00% | 0.19% |
Aquestive Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 231 institutional investors and hedge funds held shares of Aquestive Therapeutics Inc. The most heavily invested institutionals were:
Bratton Capital Management, L.P.: 9.81 M
BlackRock, Inc.: 8.07 M
RTW INVESTMENTS, LP: 7.43 M
VANGUARD CAPITAL MANAGEMENT LLC: 4.58 M
FEDERATED HERMES, INC.: 3.11 M
STATE STREET CORP: 2.93 M
58.98% of Aquestive Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 85.43 M shares in the last 24 months. This purchase volume represents approximately $366.48 M in transactions.